1. A simple, rapid solvent partition method is described for isolation of conjugated bilirubin, free of unconjugated bilirubin, bile salts, phospholipids and cholesterol, from rat bile. Yields are 40-58%. The product is a phosphate-buffered solution containing approx. 0.4mg of bilirubin/ml, principally as mono-and diglucuronide conjugates. The method may be modified for isolation of conjugates from human bile with 15-22% yield, and for preparation of unconjugated bilirubin from rat or human bile with yields of 55-62%. 2. The conjugated pigment has red-brown fluorescence and an absorption maximum at 450nm with Emu 59.8 cm-. Diazotization by the Malloy-Evelyn method gives a direct Van den Bergh raaction (in water) 12% greater than the total reaction (in methanol), with Etotal 28.4 x 103I1mo1-cm-at 550nm. After desalting by elution from Sephadex LH-20 in 50%(v/v) ethanol, the product gave water-soluble mustard-yellowerystalline needles.
LH-20 in 95% (v/v) ethanol or by extraction with chloroform at pH 3.2-3.4. The monoconjugated bilirubin did not become labelled during incubation with unconjugated [14C]bilirubin, and chromatographed as a single spot without dissociating into unconjugated bilirubin and diglucuronide as would be expected of a complex. 5. After intravenous injection ofmono-or di-conjugated [14C]bilirubin into normal or Gunn rats, 79-91% was excreted in bile and 2-7% in urine over 2h. In these experiments injected diglucuronide was not hydrolysed whereas 30-41% of injected monoglucuronide was converted into diglucuronide by the normal but not by the Gunn rats. The evidence favours the existence of a true bilirubin monoglucuronide that is not a complex.
The need for a pure preparation of conjugated bilirubin has been stressed in several reviews (Lester & Troxler, 1969; Brodersen & Jacobsen, 1969) . Existing methods for the isolation of conjugated bilirubin are often lengthy, low in yield, inappropriate for preparative work, and give products of unspecified purity (Polonovski & Bourrillon, 1952; Najjar & Childs, 1953; Cole, Lathe & Billing, 1954; Sakamoto, Yamamoto, Yahata & Kondo, 1957; Sato & Saitoh, 1965; Brodersen, 1966; Kuenzle, Sommerhalder, Riittner & Maier, 1966; Fog & Bakken, 1967) . Even the two best preparations contain impurities (Lucassen, 1961; Talafant & Appelt, 1968) The preparation ofradioactively labelled conjugated bilirubin has not been reported. In the present paper a rapid simple procedure is described for isolation of labelled conjugated bilirubin from rat bile with yields averaging 50%.
The procedure consists of two major parts. (1) Extraction of the lipid components (unconjugated bilirubin, phospholipid and cholesterol) from bile at pH 6.0 by a modification of the solvent partition method of Folch, Lees & Sloane-Stanley (1957) , associated with precipitation of proteins at the interphase. (2) Preferential extraction of bilirubin into ethyl acetate at pH 3.2-3.4, leaving taurineconjugated bile salts in the aqueous phase. The product is a solution in 50mM-sodium phosphate buffer, pH 6.5, of bilirubin diglucuronide and monoglucuronide. Human bile may be treated by a modified procedure that gives predominantly bilirubin diglucuronide. Methods are also described for preparation and crystallization of unconjugated bilirubin from rat or human bile, and for separation of bilirubin monoglucuronide and diglucuronide. The properties of the purified pigments and studies of their interconversion in vivo are also reported.
MATERIALS AND METHODS
Preparation of conjugated bilirubin from rat bile Chemicals. Unconjugated [14C]bilirubin (43.6 x 103d.p.m./,ug) was prepared biosynthetically in the rat from precursor 8-amino[14C]laevulic acid (Tracerlab Inc., Waltham, Mass., U.S.A.) and isolated and crystallized from the bile by the method of Ostrow, Hammaker & Schmid (1961) . Unlabelled, unconjugated bilirubin was purchased from the Pfahnstiehl Co., Waukegan, Ill., U.S.A. Sodium [24-'4C] taurocholate was purchased from Tracerlab, and when examined by t.l.c. (Kottke, Woilenweber & Owen, 1966) was pure except for 0.2% ofthe label in unconjugated cholic acid. All other chemicals were purchased from J. T. Baker Co., Phillipsburg, N.J., U.S.A., and were reagent grade except for spectral-quality chloro'-form, methanol and ethyl acetate.
Animal procedures. Male Sprague-Dawley rats (300-400g body wt.) were anaesthetized with intraperitoneal pentobarbital and provided with external bile fistulae. The rats were infused via a femoral venous catheter with 2.5% (w/v) glucose-0.45% NaCl solution at 1.5-2.0ml/h. To deplete the bile of bile salts, 5% (w/w) cholestyramine (Cuemid; Merck and Co., Rahway, N.J., U.S.A.) was included in the diet for 3 days before surgery. Alternatively, bile drainage with the enterohepatic circulation interrupted was extended over 24 h. For each rat 4-5mg of 14C0 labelled or unlabelled unconjugated bilirubin was dissolved in 1.0ml of 0.1M-NaOH and diluted to 5.Oml with 4% (w/v) human serum albumin (Nutritional Biochemical Corp., Cleveland, Ohio, U.S.A.) in 50mM-sodium phosphate buffer, pH 7.0. The solution, adjusted to pH 7.4 and stored on ice in the dark, was administered intravenously in five 1.0ml doses at 90min intervals. Bile (lOml) was collected on ice and in the dark during the 8-lOh period after the first injection. A portion was analysed for bilirubin concentration by a micro-modification of the method of Malloy & Evelyn (1937) and radioassay was performed as described below.' After addition of a pinch of solid ascorbic acid, the remainder was stored at -15°C.
Isolation of the conjugated bilirubin from rat bile. During development of the procedure, E450 values were used to measure bilirubin concentration and [14C]taurocholate was used as a marker for bile salts since rats do not excrete glycine-conjugated bile salts (Haslewood, 1955) . Once the definitive procedure had been adopted, yields of bilirubin were determined both from bilirubin radioactivity and by the Malloy & Evelyn (1937) diazo method. For radioassay, 10ml of dioxan-based scintillator (Bray, 1960 ) was added to: (a) 0.1ml of bile blended with 0.2ml of MHyamine in methanol (Rohm and Haas Co., Philadelphia, Pa., U.S.A.); (b) 0.2-0.5 ml of aqueous phases or solutions; (c) 0.5 ml of organic phases evaporated to dryness.
The isolatiosi was performed in dim light by using 125ml separation funnels adapted for centrifuging in special trunions (International Equipment Co., Needham Heights, Mass., U.S.A.). Emulsions were thus resolved by centrifugation at every stage. Bile, fresh or thawed, was centrifuged for 15min at 4°C and 20000gav. and the supernatant was adjusted to pH 7.0 with m-HCI. (1) (Folch extraction): neutralized bile (10 ml) was added to 60ml of methanol-chloroform (1:2, v/v) and shaken. Then 5ml of 0.1 M-sodium phosphate buffer, pH5.8, was added and the mixture was thoroughly shaken. The lower phase and the 'button' at the interphase were discarded. (2) The upper phase, containing conjugated bilirubin and bile salts, was extracted again with an equal volume of fresh pre-equilibrated lower phase, prepared as above with 0.85% NaCl in place of bile, and the lower phase was again discarded. (3) Methanol remaining in the upper phase from step (2) was extracted into an equal volume of chloroform, which was discarded. (4) The upper phase from step (3) was extracted with an equal volume of light petroleum (b.p. 30-60°C) , which was also discarded. (5) The lower (aqueous) phase from step (4) was adjusted to pH 3.2-3.4 with M-HCI and shaken with 3 vol. of ethyl acetate. The aqueous phase, containing most of the bile salts, was discarded. (6) The upper organic phase from step (5) was shaken with 0.1 vol. of 0.1 M-sodium phosphate buffer, pH 7.4, and the organic phase discarded. (7)- (9) The lower aqueous phase from step (6), which contained almost all remaining conjugated pigment and bile salts, was subjected again to steps (5), (6) and (5). (10) The upper organic phase from step (9) was shaken with 2-3 ml of 50mM-sodium phosphate buffer, pH 7.4, and discarded. (11) The aqueous phase from step (10) was extracted with 2 vol. of chloroform and both phases were kept. (12) The chloroform phase together with all overlying precipitate was extracted with 2 ml of 50 mM-sodium phosphate buffer, pH 5.8, which was then added to the aqueous phase (pH 7.4) from step (11). The pooled aqueous phases constituted the final product, which was shown (see below) to be a mixture of bilirubin conjugates in 50mM-sodium phosphate buffer, pH6.5. It was stored under air at -15°C, and is referred to below as 'CBM preparation'.
I8olation of conjugated bilirubin from human bile. Sterile human bile was obtained 5-7 days post-operatively from T-tube drainage of the common duct of patients with normal liver function not receiving drugs excreted as organic anions in the bile. The procedure was the same as for rat bile, except for an extra step in which the aqueous phase from step (4) was adjusted to pH 3.5 and glycineconjugated bile salts, which predominate in human bile (Haslewood, 1955) , were extracted twice with 3 vol. of chloroform. The aqueous supernatant was then subjected to step (5) without further adjustment of pH. The efficiency of this extraction was monitored by using radiochemically pure [14C]glycodeoxycholate as a tracer (kindly provided by Dr Alan F. Hofmann, Rochester, Minn., U.S.A.). Radioassay was performed as described for rat bile.
Isolation of unconjugated bilirubin from rat and human bile. Rat or human bile was processed as in steps (1)-(4).
To the aqueous phase from step (4) a pinch of ascorbic acid and I vol. of4m-NaOH was added. After being stirred in the dark for 30min to hydrolyse bilirubin conjugates, the solution was adjusted to pH6.0 with 12M-HCl and extracted twice with 1 vol. of chloroform to recover the unconjugated bilirubin. The pooled chloroform extracts 1970 312 were washed once with 10% (w/v) NaCl, thrice with water, and then filtered through chloroform-saturated Whatman no.40 paper. Unconjugated bilirubin was then crystallized and recrystallized by displacement of the chloroform with methanol over a boiling-water bath (Ostrow et al. 1961 ).
Desalting and crystallization of conjugated bilirubin
Desalting by column chromatography. Columns (1 cm x 13cm) of gels were prepared in various proportions of methanol, ethanol or propan-2-ol with water. Bio-Rad AG-11 A8 (California Biochemicals Corp., Los Angeles, Calif., U.S.A.), Amberlite XAD-2 (Rohm and Haas Co.) and Sephadex LH-20 (PharmaciaFine Chemicals, Uppsala, Sweden) were used as stationary phases, and were packed in columns and eluted with the same solvent. CBM preparation (0.5 ml) was layered on to the gel and eluted in the dark at 20°C. Fractions (1 ml) were collected on ice, the pigment content in each being determined by the diazo method of Malloy & Evelyn (1937) ; phosphate was detected by precipitation with 10% (w/v) BaCl2. Fractions containing pigment but no phosphate were pooled and vacuum-distilled under N2 in actinic glass flasks at 30°C.
Desalting by acid-washing. The ethyl acetate phase from step (9) was washed twice with 0.5vol. of mM-HCl and then vacuum-distilled to a small volume as described above.
Crystallization. This was attempted by gradual addition of acetone to the column eluate or the addition of chlorobenzene to the acid-washed ethyl acetate phase, followed by vacuum-distillation.
Properties and purity of the CBM preparations Chemical determinations. Bilirubin concentrations were determined by the Malloy & Evelyn (1937) method, with water as diluent for the direct Van den Bergh reaction and methanol for the total reaction. Both were read at 15 min when colour development was completed and stable. Unconjugated bilirubin was also determined as chloroform-extractable pigment at pH 6.5 (Brodersen & Vind, 1963) . Cholesterol, bile salt and phospholipid assays were kindly performed by Dr Dewey Neiderheiser, Cleveland, Ohio, U.S.A. (Neiderheiser & Roth, 1968) .
Chromatography of pigments. Concentrates of labelled pigments were subjected to ascending paper chromatography as described by Noir, Garay & Royer (1965) (Ostrow et al. 1961 ) for counting of radioactivity. The azo-pigment extract was similarly assayed after appropriate dilution. Absorption spectra. These were determined from 300-700nm in spectral-quality solvents with a recording spectrophotometer (Beckman model DB).
Molar extinction coefficients of pigments and azo-pigments. These could not be measured directly since the conjugated pigments were never obtained in pure crystalline form. Values were instead determined on solutions of 14C-labelled conjugates whose exact content of bilirubin was calculated from total radioactivity, corrected for labelled impurities revealed by pigment chromatography, multiplied by the specific radioactivity of the conjugated bilirubin. This last was equal to the specific radioactivity of the crystalline unconjugated [14C]bilirubin obtained by alkaline hydrolysis of the conjugate, with pure crystalline unconjugated bilirubin as reference standard (Ostrow etal. 1961) .
Stability. The stability of CBM preparations was assessed during storage at -15°C and during incubation at 37°C, both in air and in the dark. Oxidation and hydrolysis were determined from changes in the direct and total diazo reaction (Ostrow, 1967) , changes in absorption spectra and changes in the patterns of pigment and azopigment chromatograms (see above).
Separation of bilirubin monoglucuronide and diglucuronide Column chromatography. Columns of Sephadex G-10 or LH-20 (Pharmacia) or Bio-Gel P-2 (Calbiochem) were prepared, eluted, and analysed as described under 'Desalting by column chromatography'. Solutions applied to the columns included 0.5 ml of neutralized bile, the aqueous phase from the second Folch extraction [step (2)] or the purified conjugates in phosphate buffer. With the first two solutions, ['4C]taurocholate was added as a bilesalt marker and the radioactivities of the eluted fractions were counted in Bray's scintillator (see above).
Solvent partition. CBM preparation adjusted to pH 3.3 with m-HC1 was extracted four times with an equal volume of chloroform. At each extraction the chloroform phase was transferred to a tube containing 1 vol. of 50mM-sodium phosphate buffer, pH6.5, and the interphase precipitate was retained with the aqueous phase for re-extraction. The final aqueous phase and precipitate were adjusted to pH6.5, shaken with an equal volume of chloroform and centrifuged, and the chloroform was discarded. The yellow supernatant contained predominantly bilirubin diglucuronide and is referred to below as 'fraction CB-IJ'. Pigments from the pooled chloroform extracts, which consisted mainly of bilirubin monoglucuronide, were recovered by two washes with small volumes of 50mM-sodium phosphate buffer, pH 6.5, and are referred to below as 'fraction CB-I'.
Nature of the conjugated bilirubins Clucuronic acid. This was determined in solutions and detected in chromatographic spots by the methods of Fishman & Green (1955) and Noiretal. (1965) Excretion and interconver8ion of bilirubin conjugate8 in the rat. Solutions of 14C-labelled fractions CB-I and CB-II were injected intravenously into 300-400g male Wistar or jaundiced Gunn rats with external bile fistulae. Each rat received both fractions of bilirubin conjugate preparation successively with an interval of 4 h and with the sequence randomized among the animals studied. For 4 h after each injection all bile and urine were collected on ice in the dark, with bile of successive 30, 90 and 120 min intervals saved as separate fractions. The radioactivity of one-tenth of each bile fraction warmed with 0.5ml of M-Hyamine, or 0.5ml of urine, was counted after addition of 10ml of Bray's scintillator. The remainder of the first two bile fractions were pooled, and both pigment and ethyl anthranilate azo-pigment extracts were prepared, chromatographed and assayed as described above. Portions of the injected solutions were treated similarly and their total bilirubin concentrations determined by the method of Malloy & Evelyn (1937 Statistical methods (Edwards, 1954) . Mean values are given with standard errors, calculated with the Yates' correction for small populations. Significance ofdifferences between means was calculated by Student's t test. Regression lines in Fig. 9 were calculated by the method of least squares.
RESULTS

Isolation of bilirubin-conjugate preparation from bile
Conditionsfor Folch extractions [steps (1) and (2)]. Completeness of the extraction of unconjugated [14C] bilirubin from bile into the lower phase increased as pH was decreased (Fig. 1) . Less than 6% of the unconjugated bilirubin remained in the upper phase if the buffer pH was 5.8-6.0, and less than 3 % if, in addition, the pH of the bile was first adjusted to 7.0. A fivefold increase in the proportion of bile to chloroform-methanol had little effect on the extraction of unconjugated bilirubin but progressively diminished the retention of conjugated bilirubin in the upper phase ( Fig. 2) , the remainder being lost in the proteinaceous 'button' at the interphase. A ratio of lOml ofbile to 60ml ofchloroformmethanol was chosen as the optimum compromise between maximum yields of conjugated bilirubin Initial pH of aqueous phase Vol. 120 III~~8 8 I Yields of conjugated bilirubin. These, assessed from both diazo-reactivity and radioassay, ranged from 42 to 60% of the total [14C]bilirubin in the initial rat bile. A lOml portion of bile from one rat gave a final CBM preparation containing 2.0-2.5mg of bilirubin in 5.Oml. With human bile yields were lowered to 15-22% by losses of pigment during extraction of the glycine-conjugated bile salts, but concentrations of bilirubin in human CBM preparations ranged from 0.6 to 1.0 mg/ml according to pigment concentration in the initial bile.
Preparation of unconjugated bilirubin from bile. less than 1%/day. When incubated in the dark at 37°C under air at pH 7.0 the rate of oxidation was less than 1%/h. Chromatography of the oxidized pigments (Fig. 7) revealed two additional green spots Of RF 0.20-0.33 and 0.30-0.43, corresponding to di-and mono-conjugated biliverdins respectively (Noir et al. 1965 (Tables 4 and 5 ). The calculations diazo reaction were based on the fact that bilirubin diglucuronide ues were inde-gives only &-azo-pigment whereas the monogluculirubin mono-ronide gives equal quantities of a-and 8-azo-pig-3 preparations, ments , and on the assumped to the same tions that all a-azo-pigment was derived from the diazo reaction monoglucuronide and all remaining 8-azo-pigment ion was added was derived from the diglucuronide. The proportions of,-and y-azo-pigments formed from fractions the dark under CB-1 and CB-II were similar to those formed from zed at a rate of the original CBM preparation. Glucuronic acid/bilirubin ratios. Glucuronic acid/ bilirubin ratios for all CBM and fraction CB-1 preparations were close to those predicted from the proportions of 8-azo-pigment to total ethyl anthranilate azo-pigments formed from the preparation (Table 3) . These findings confirmed the higher proportion of bilirubin monoglucuronide in rat than in human bile preparations, and also the predominance of the monoglucuronide in fraction CB-1. Glucuronic acid/bilirubin ratios for fraction CB-11 ranged from 2.78 to 3.53, well above values predicted from azo-pigment assays. However, if the pigments were first diazotized and then extracted into pentan-2-one-butyl acetate, leaving unbound glucuronic acid in the aqueous phase, the glucuronic acid/bilirubin ratio in the azo-pigment extract now concurred with the proportion of 8-azo-pigment in the extract (Table 3) . Less than 2% of the original bilirubin colour (E450) remained in the aqueous phase after extraction, indicating that diazotization of the bilirubin conjugates was essentially complete.
Hydrolysis ofpigments from 14C-labelled CJBM preparations with (3-glucuronidase. This was completed by 30min. On diazotization, it was found that 94% of the 14C radioactivity was lost from the 8-azopigment and now appeared in the a-azo-pigment and F spot. The (3-and y-azo-pigments were unaffected.
Hydrolysis of "4C-conjugated azo-pigments with alkali. This treatment eliminated the 8-and y-azopigments. The (-azo-pigments were unaffected and the ao-azo-pigment and F spot increased. However, despite addition of ascorbic acid to minimize oxidation, half the diazo-reactivity was lost during hydrolysis. Vol. 120 Table 3 . Glucuronirc acid/bilirubin molar ratio8 in purified preparatior& of conjugated bilirubin Values on the left in each column were determined spectrophotometrically by the method of Fishman & Green (1955) for glueuronic acid and the Malloy & Evelyn (1937) Normal and Gunn rats are denoted N and G respectively. The injected dose, given as bilirubin irrespective of conjugated moieties, was determined by the diazo method. The percentages of bilirubin monoglucuronide and diglucuronide refer to the proportion of total injected radioactivity in each conjugate, determined from chromatography of the ethyl anthranilate azo-pigments (see Table 5 ). Fraction CB-II was obtained as aqueous phase readjusted to pH 7.4 after chloroform extraction of CBM preparations at pH3.3. Fraction CB-I was the bilirubin extracted into chloroform from CBM preparations at pH3.3, and subsequently transferred back to 50mm-sodium phosphate buffer, pH7.4. Abbreviations: BMG, bilirubin monoglucuronide; BDG, bilirubin diglucuronide; N.S., not significant. Animals and injected solutions were identical with those described in Table 4 . The percentage of azo-pigment is the percentage of total 14C radioactivity in the injected solution or in the bile excreted in 2h that was found in a-or 8-azo-pigment on t.l.c. The increment (%) is the percentage of excreted 14C radioactivity in a-(or S-) azo-pigment minus the percentage of injected 14C radioactivity in that azo-pigment. The mean increment (%) is the average of increments for a-and 8-azo-pigments with the sign reversed for the o-azo-pigment increment.
Since there are 2mol of azo-pigment formed/mol of bilirubin, the amount of bilirubin monoglucuronide converted into diglucuronide is twice the mean increment multiplied by the dose of bilirubin injected (,Lg/lOOg body wt. from Table 4 (Table 4) . During a period of 2h after intravenous administration of labelled preparations of fraction CB-I or CB-II, 79-91% of the radioactivity appeared in the bile and 2-7 % in the urine irrespective of the proportions of bilirubin monoglucuronide and diglucuronide injected. However, during the first 30min significantly more 14C radioactivity was excreted in the bile when the diglucuronide, rather than the monoglucuronide, was the predominant pigment. With both fractions CB-I and CB-II, another 4-9% of the injected 14C radioactivity appeared in the bile during the third and fourth hour. Excretion rates were the same for Gunn rats as for normal rats.
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Interconversion of bilirubin monoglucuronide and diglucuronide in the rat (Table 5 ). The excreted and injected bile pigments exhibited identical distributions of radioactivity in non-diazotizable biliverdin conjugates and in the F, ,B, y and 0 spots of the ethyl anthranilate azo-pigment chromatograms.
However, in normal rats there was an increase in the proportion of 8-azo-pigment (glucuronide) and a corresponding decrease in the proportion of aazo-pigment (unconjugated). By contrast, the proportions of oc-and 8-azo-pigments were virtually unchanged by passage through Gunn rats. Duplicate determinations on individual samples never differed by more than 2.2%. Assuming that all the c-azo-pigment was derived solely from bilirubin monoglucuronide, it was calculated that the normal rats converted 36.4 + 1.7% of the injected bilirubin monoglucuronide into diglucuronide, whereas only 5.0+0.4% was converted by Gunn rats (P<0.001).
These proportions applied irrespective of the dose of bilirubin monoglucuronide and of the relative amount of bilirubin diglucuronide administered simultaneously (Fig. 9) . Bioch. 1970, 120 Vol. 120 321 Bilirubin monoglucuronide injected (,g/lOOg body wt.) Fig. 9 Talafant & Appelt (1968) . [Lucassen (1961) obtained 0.3g of bilirubin from 1 litre of human T-tube bile. He did not state the bilirubin concentration in the initial bile, but it presumably fell in the range 0. 5-1.5 g/l (Guldhammer & Kjeldsen, 1967) .]
Disadvantages of the present method are: (1) large volumes of solvent are required, making it uneconomical for bulk isolation of pigments; (2) failure to obtain adequate quantities of crystalline material, although the CBM preparations are suitable for physiological studies, as was demonstrated; (3) the product slowly oxidizes during storage, whereas Lucassen's (1961) crystalline preparation is stable; both preparations are otherwise similar as to colour, fluorescence, spectra and solubilities. Thus Lucassen's (1961) method seems preferable for the bulk isolation of bilirubin diglucuronide from human bile, whereas the present method is better for rapid isolation of mixed or individual conjugates from multiple small samples of rat bile.
The modified procedure for preparation of unconjugated bilirubin from bile is simpler and more rapid than the generally used method of Ostrow et al. (1961) and avoids the troublesome extraction of pigment from a proteinaceous gel that bedevils the older method. Both procedures give comparable yields and are applicable to microquantities of bile and bilirubin.
Separation of bilirubin mono-and di-glucuronide.
Significant but incomplete separation of bilirubin monoglucuronide from diglucuronide was achieved by both chloroform extraction at pH3.3 and by elution from Sephadex LH-20 with 95% (v/v) ethanol. The solvent partition procedure involved large losses due to precipitation, hydrolysis and oxidation of pigment, especially of bilirubin monoglucuronide. The column chromatographic procedure gave over 90% recovery of pigment but no more than 1.0g of bilirubin conjugates could be processed on a 1 cm x 13cm bed of gel. Jacobsen (1970) has reported complete separation of the two conjugates by a similar procedure from a Lucassen (1961) preparation applied to Sephadex LH-20 and eluted with 50% (v/v) ethanol, but further examination of the purity of his two pigment fractions seems warranted before it can be decided whether elution with 95% or 50% ethanol is preferable.
Properties of the conjugated pigments Spectra. The two-peaked absorption spectrum of conjugated bilirubin has been described by Polonovski & Bourrillon (1952) , Cole et al. (1954) , Lucassen (1961) , Maggiore & Giovannetti (1965 , Kuenzle et al. (1966) and Fog & Bakken (1967) . The two maxima were identical for the purified pigment and for whole bile, indicating that they are not, as suggested by Polonovski & Bourrillon (1952) and and by Maggiore & Giovannetti (1965) may perhaps be attributed to their use of different solvents for the two pigments. The present study documents solvent effects on the relative intensity of the two maxima and suggests that, in solution, each conjugate may exist in two forms in dynamic equilibrium, dependent on variations of intra-or inter-molecular hydrogen-bonding (Fog & Jellum, 1963) or on keto-enol tautomerism (Gray, Kulezycka & Nicholson, 1961) . The extinction coefficient at 450nm is the same for conjugated pigment in methanol or water as for unconjugated bilirubin in chloroform, suggesting that conjugation does not affect the electronic properties of the chromophore. Malloy-Evelyn diazo reaction. The azo-pigment absorption maxima were at 560nm in aqueous and at 550nm in methanolic solution. Jirsa & Jirsova (1959) presented spectra of the azo-pigment of a synthetic taurobilirubin conjugate that showed a similar shift ofthe maximum to shorter wavelengths in methanol, although their text stated that the maximum was identical in the two solvents. The millimolar extinction coefficient of 28.4cm-1 for our preparation agrees with values obtained by Overbeck, Vink & Deenstra (1955) , and by Lucassen (1961) after correction of the latter's value for the weight of impurities in his crystals.
Although Jirsa & Jirsova (1959) and Billing, Cole & Lathe (1957) noted an increase in the diazo reaction of monoconjugated bilirubin on addition of alcohol, our purified preparations consistently yielded more colour in the aqueous (direct) reaction. However, when CBM preparation was added to human or rat serum, the direct reaction was inhibited with extinction 15% less than the total reaction. However, the total diazo reaction of serum was of similar intensity with CBM preparations and unconjugated bilirubin. Therefore use of unconjugated bilirubin as a standard for conjugated bilirubin is valid only for the total diazo reaction, and the proportion of conjugated bilirubin in serum is consistently underestimated by the direct Malloy-Evelyn diazo reaction currently used in many clinical laboratories.
Solubility. The solubility of the pure conjugated bilirubin in water and its precipitation by Pb2+ ions confirms previous findings with impure preparations (Ostrow et al. 1961; Talafant, 1956 ), but the solubility of desalted pure conjugates in the presence of Ca2+, Ba2+ and Zn2+ differs from the ready coprecipitation of conjugated bilirubin when these cations are added to whole bile (see Ostrow et at. 1961, references 51-59) . The solubility of the calcium salt of conjugated bilirubin supports the hypothesis that pigmented biliary calculi develop when the conjugate is hydrolysed by bacterial fl-glucuronidase, forming the insoluble calcium salt of unconjugated bilirubin (Maki, Sato & Saitoh, 1962; Suzuki & Toyoda, 1966) .
Stability. The pure CBM preparations, like Brodersen's (1966) adsorbate of bilirubin diglucuronide to Super-Cel, underwent very slow oxidation to biliverdin conjugates, but no hydrolysis when stored at -15°C and even when incubated at pH 7.0 in the dark in air at 37°C. This contradicts claims (Nosslin, 1960b; Lucassen, 1961) that bilirubin conjugates are very unstable in proteinfree solutions, and contrasts with the often rapid hydrolysis and oxidation of conjugated bilirubin in bile incubated under similar conditions (Ostrow, 1967) . Whether the instability of conjugated bilirubin in bile is due to complex-formation with other constituents or to enzymic action is not yet known. The stability of the pigments in the aqueous CBM preparations is important, since it permits for the first time the use of pure conjugated bilirubin in incubation studies in vitro.
Nature of the biltirubin conjugates. CBM preparations and fractions CB-I and CB-JI were shown, by paper and column chromatography, by azopigment chromatography and by glucuronic acid/ bilirubin ratios, to be composed predominantly of mixtures of bilirubin monoglucuronide and diglucuronide. There was a paucity of bilirubin monoglucuronide in human CBM preparations, whereas rat CBM preparations contained up to two-thirds bilirubin monoglucuronide. This is well above values reported for normal rat bile (Hoffman, Whitcomb, Butt & Bollman, 1960) , even allowing for the increased proportion of the monoglucuronide that is excreted after intravenous loading with unconjugated bilirubin (Hoffman et al. 1960; Schalm & Weber, 1962; Verme & Camarri, 1965; DiazRubio, Diaz-Rubio & Santos, 1967) . However, column chromatography of the original bile samples and their Folch extracts showed 25-35% bilirubin monoglucuronide, in agreement with reported values (Billing et al. 1957; Hoffman et at. 1960; Kuenzle et al. 1966; Inoue, 1966) . These discrepancies are probably due to preferential extraction of bilirubin monoglucuronide into ethyl acetate [rat bile procedure, steps (5), (7) and (9) Although murine and human bile contain preponderantly bilirubin diglucuronide and monoglucuronide, azo-pigment chromatography reveals the existence of other conjugates (Tenhunen, 1965; Gaidano, Pagliardi & Fevero, 1965; Inoue, 1966) . Some of these are resistant to ,-glucuronidase and some even to alkaline hydrolysis (Isselbacher & McCarthy, 1959; Gaidano et al. 1965; Colombo & Bonomo, 1965) . Alkali-stability has also been demonstrated directly with undiazotized bilirubin conjugates separated by t.l.c. (Manenti, Solmi & Spanio, 1966) . In the present study with ethyl anthranilate azo-pigments, 6% ofthe 8-fraction and all of the y-and aB-fractions were resistant to ,-glucuronidase, and the a-fraction was also resistant to alkali, confirming observations of . Some of these resistant azo-pigments, which derive from minor bilirubin conjugates in rat or human bile, are not sulphate conjugates (Isselbacher & McCarthy, 1959; Tenhunen, 1965; Colombo & Bonomo, 1965; Manenti et al. 1966; Compernolle et al. 1970 ). Since fractions CB-I and CB-II gave other azo-pigments in addition to the a-and 8-azo-pigments, these preparations of bilirubin monoglucuronide and diglucuronide are contaminated with small proportions of other conjugates of bilirubin.
It is currently believed that bilirubin 'monoglucuronide', represented by the pigment I fraction isolated by reverse-phase partition chromatography of serum from jaundiced patients, is a complex since it partly dissociates into unconjugated bilirubin and pigment II on rechromatography (Nosslin, 1960a; Gregory, 1963; Weber, Schalm & Witmans, 1963) or heating (Billing & Lathe, 1958) . Nosslin (1960a) has also recovered unconjugated bilirubin from pigment I by extraction with chloroform at neutral pH, a procedure designed to extract unconjugated bilirubin completely from complex mixtures (Brodersen & Vind, 1963) . Moreover, Nosslin (1960b) and Weber et al. (1963) have reconstituted a pigment I band by chromatography of mixtures of unconjugated bilirubin, pigment II, and serum.
On the other hand, in conjugated hyperbilirubinaemia the proportion of chloroform-extractable bilirubin is not increased (Tygstrup & Brodersen, 1968) although the proportion of the pigment I fraction is uniformly elevated (Hoffman et al. 1960; Schoenfield, Bollman & Hoffman, 1962; DiazRubio & Diaz-Rubio, 1966) . Schoenfield & Bollman (1963) were unable to dissociate the pigment I band found in the serum of hepatectomized dogs. Apparently in these two circumstances the pigment I is not a complex of unconjugated bilirubin and bilirubin diglucuronide. This is certainly true of the purified bilirubin monoglucuronide isolated in the present studies, since this was not dissociated by chloroform extraction, the Folch solvent partition procedure or rechromatography, did not exchange with unconjugated [14C]bilirubin and, on oxidation, formed only biliverdin monoglucuronide. Moreover, when administered intravenously to Gunn rats that cannot excrete unconjugated bilirubin (Lester, Klein & Matusen, 1966) , [14C]bilirubin monoglucuronide was quantitatively excreted, even when little bilirubin diglucuronide was present. This cannot be accounted for by excretion of a complex of unconjugated bilirubin and bilirubin diglucuronide since large amounts of the diglucuronide have to be injected to carry over a small amount of unconjugated bilirubin (Callahan & Schmid, 1969) .
The evidence thus favours the existence of two forms of bilirubin 'monoglucuronide', one a complex of unconjugated bilirubin and bilirubin diglucuronide and the other a true monoglucuronide. It is suggested that the former be referred to as pigment I, the latter as bilirubin monoglucuronide.
Excretion of bilirubin conjugates by the rat. The observed rates of biliary excretion of purified
[14C]bilirubin conjugates agree closely with values obtained by after intravenous administration of the conjugates as whole bile, and by Although output of bilirubin monoglucuronide and diglucuronide was similar at 2h, excretion of bilirubin monoglucuronide was initially delayed in both Gunn and normal rats. The delay thus cannot be attributed to a rate-limitation in the conjugation of bilirubin monoglucuronide but probably results from slower excretion of the monoglucuronide per se. Urinary excretion of the monoglucuronide and diglucuronide were comparable, indicating that both can pass the glomerulus. Other authors agree, although they differ as to which pigment predominates in icteric urine (Cole et al. 1954; Schachter, 1959; Verme & Camarri, 1965; Hoenig & Jirsa, 1966) . By using the Schachter (1959) azopigment partition method, which unfortunately may not accurately measure proportions of bilirubin monoglucuronide and diglucuronide in urine, Diaz-Rubio, Diaz-Rubio & Agullo (1966) found that renal clearance ofthe diglucuronide was greater than that of the monoglucuronide. This would be expected from the higher pK and greater lipidsolubility of bilirubin monoglucuronide, which should lead to increased back-diffusion of this conjugate from the tubular fluid at low pH values (Ali & Billing, 1966) .
Interconversion of bilirubin monoglucuronide and diglucuronide in the rat. Since neither bilirubin monoglucuronide nor the diglucuronide was administered in pure form free from other conjugates, certain assumptions had to be made in interpreting the results of these studies.
(1) It was assumed that differential excretion of the two conjugates did not 1970 324 account for the increased proportion of bilirubin diglucuronide in the bile. This is validated by two observations: (a) the percentage of pigment excreted in 2h and the proportion of administered bilirubin monoglucuronide converted into diglucuronide were unaffected by wide variations in the ratio of the two glucuronides injected; (b) in some animals the fraction of injected radioactivity that was not recovered in the excreta was too small to account for the calculated conversion of monoglucuronide into diglucuronide, even if all the unrecovered label were in monoglucuronide. (2) In calculating the absolute conversion of bilirubin monoglucuronide into diglucuronide it was assumed that labelled pigments excreted during the first 2h were representative of the total output of labelled pigment. This seems probable since the distribution of 14C radioactivity in the bile pigments excreted in the third and fourth hour was the same as in the first 2h in the two animals thus examined. (3) It was assumed that the only significant interconversions were of a-and 8-azo-pigments, which is supported by the finding that the proportion of 14C radioactivity in the F, ,B, y and 0 fractions were the same for the excreted and injected pigments of each animal. Moreover, conjugated biliverdins in the injected solutions were recovered intact in the bile, indicating that, unlike unconjugated biliverdin (Goldstein & Lester, 1964) , they need not be converted into bilirubin conjugates to be excreted. Apparently the rat cannot conjugate biliverdin.
Since less than 60% of the excreted radioactivity was recovered with pigments extracted by the method of Noir et al. (1965) , spurious increases in the bilirubin diglucuronide fraction could have been observed if bilirubin monoglucuronide were selectively lost. To circumvent this problem proportions of the two conjugates were determined by chromatography of their ethyl anthranilate azopigments, with recovery of over 85% of the excreted radioactivity and almost 100% of the excreted bilirubin conjugates. However, use of the proportions of a-and 8-azo-pigments to calculate the relative amounts of bilirubin monoglucuronide and diglucuronide involved assumptions that all a-azopigment was derived from bilirubin monoglucuronide and all 8-azo-pigment came from either bilirubin monoglucuronide (a-8) or bilirubin diglucuronide (8-8). Since no unconjugated bilirubin was demonstrated by chloroform extraction, all a-azopigment of the injected and excreted solutions must have been derived from monoconjugated bilirubins. The other assumption is supported by the studies of Heirwegh et al. (1970) with rat bile pigments separated on ion-exchange columns with formamide gradients. Their bilirubin diglucuronide frpctiQn yielded only 8-azo-pigments, and 8-azo-pigments were formed only from the bilirubin monoglucuronide and diglucuronide fractions. It thus seems valid in the rat to calculate the relative amounts of bilirubin monoglucuronide and diglucuronide from the proportions ofazo-pigments a and 8 formed from a mixture of conjugates as follows: % monoglucuronide (= x+equimolar 8) = 2 x %oc, and % diglucuronide (= residual 8) -0/ 8 -% a.
The above assumptions are further validated by the finding that Gunn rats, which cannot synthesize glucuronide conjugates of bilirubin, showed little increase in the proportion of bilirubin diglucuronide in the excreted as compared with injected pigments, an increment well within experimental error and significantly smaller than the increment found with normal animals. A further safeguard was the use of each rat as its own control, each receiving fractions CB-I and CB-II in a sequence randomized among the six animals. The results demonstrated net conjugation of bilirubin monoglucuronide to the diglucuronide, as shown previously for the intact rat by Schoenfield & Bollman (1963) and in the isolated perfused rat liver by Schoenfield, Grindlay, Foulk & Bollman (1961) . These authorshave further suggested that-the liver cannot make bilirubin monoglucuronide, since none is excreted in the bile of the isolated rat liver perfused with unconjugated bilirubin or bilirubin monoglucuronide and they found only bilirubin diglucuronide in the medium after incubation of rat liver slices or homogenates with unconjugated bilirubin. However, other inveetig4tors have'; detected bilirubin monoglucuronide production by homogenates or partially purified bilirubin glucuronyltransferase from rat liver (Van Roy & Heirwegh, 1968; Mowat & Arias, 1969; Strebel & Odell, 1969) , so the question of the hepatic versus extrahepatic origin of bilirubin monoglucuronide remains in dispute. The known increases in the pigment I fraction of plasma in hepatocellular failure (see above) and in bile after intravenous bilirubin loading (see above) can be interpreted to support either view.
The failure to find net conversion of [14C]bilirubin diglucuronide into [14C]bilirubin monoglucuronide or unconjugated [14C] bilirubin in the Gunn rats indicated that significant hydrolysis of conjugated bilirubin did not occur in these experiments. This differs from the conclusion ofOkolicsanyi, Magnenat & Frei (1968) , who injected much greater doses of conjugated bilirubin in the form of enriched native bile and observed increases in the indirect-reacting bilirubin in the excreted bile. However, they did not use labelled bilirubin to exclude the possibility that these increases came from endogenous unconjugated bilirubin carried into the bile as a complex with administered bile salts or conjugated bilirubin (Callahan & Schmid, 1969 
